Wednesday, October 18th | 28 Tishri 5778

Close

Be in the know!

Get our exclusive daily news briefing.

Subscribe
May 23, 2017 11:41 am

Israeli Start-Up BiomX Aims to Eliminate Need for Antibiotics

avatar by JNS.org

Email a copy of "Israeli Start-Up BiomX Aims to Eliminate Need for Antibiotics" to a friend

The Israeli start-up BiomX’s initial products are intended to treat acne and Helicobacter pylori bacteria (pictured). Photo: KGH via Wikimedia Commons.

JNS.org – The Israeli start-up BiomX, which last week completed a $24 million round of financing, is aiming to replace the need for conventional antibiotics by developing treatments that selectively eliminate specific bacteria.

BiomX’s treatments are developed using phages — special viruses intended to fight certain bacteria, as opposed to traditional antibiotics that kill all bacteria, including beneficial bacteria.

“BiomX has developed a platform with two elements. One is the ability to detect with precision what bacteria are missing, and which existing bacteria are causing damage. The second is the ability to selectively attack unnecessary bacteria,” said Assaf Oron, BiomX’s executive vice president of strategy and business development.

In theory, BiomX’s treatments would replace conventional antibiotics with a more selective treatment method for specific conditions. The company’s initial products are intended to treat acne and Helicobacter pylori bacteria. BiomX also has plans to develop treatments for intestinal inflammation conditions such as colitis and Crohn’s disease, as well as products for the prevention and treatment of cancer.

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner
  • Silent Majority

    This is not new. http://www.nature.com/news/phage-therapy-gets-revitalized-1.15348 Perhaps there might be better ways to target phages, but eastern European countries have extensive experience in this area.

  • Reb_Yaakov

    Antibiotics do not kill “all bacteria.” Each antibiotic has a spectrum of activity; some bacteria are sensitive to it and others are resistant to it.

Algemeiner.com